Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,958 public trials 1,252 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Active, Not Recruiting

Adaptive Symptom Self-Management Immunotherapy Study

NCT05715255

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +25 more
Locations
  • Valleywise Health Medical Center Phoenix, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT02595931

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Colonic Diseases, +42 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

NCT06305247

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +27 more
Locations
  • The Angeles Clinic and Research Institute - California Los Angeles, California, United States
  • Yale Cancer Center - New Heaven New Haven, Connecticut, United States
  • Sarah Cannon Research Institute (SCRI) - Nashville Nashville, Tennessee, United States
  • Virginia Cancer Specialist Fairfax, Virginia, United States
View Trial Details
Active, Not Recruiting

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)

NCT05464030

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • California Cancer Associates for Research & Excellence, Inc. Encinitas, California, United States
  • California Cancer Associates for Research & Excellence, Inc. Fresno, California, United States
  • Rhode Island Hospital Providence, Rhode Island, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View all 35 locations
View Trial Details
Active, Not Recruiting

A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer

NCT05009069

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, China
  • The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, China
  • Zhongshan Hospital Fudan University Shanghai, China
View Trial Details
Active, Not Recruiting

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

NCT06781983

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Diseases, +64 more
Locations
  • Massachusetts General Hospital - Boston Boston, Massachusetts, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
  • Mount Sinai Tisch Cancer Center New York, United States
  • NEXT Oncology - Dallas Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study

NCT04258137

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • Centre hospitalier de la Côte Basque Bayonne, France
  • Clinique Tivoli-Ducos Bordeaux, France
  • Institut Bergonie Bordeaux, France
  • Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
View Trial Details

Related conditions